close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by TAE Life Sciences

News headline image
Institut du Cancer de Montpellier and TAE Life Sciences Launch AMBER Project to Bring BNCT to France
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Announces Strong Commercial Progress with BNCT Partnership and Supply Chain Expansion in China
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Novel Boronated Drugs for BNCT in Combination with Immune Checkpoint Inhibitors Demonstrate Superior Tumor Growth Inhibition in Preclinical in vivo Models
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and University of Wisconsin-Madison to Bring Promising Accelerator-Based BNCT Cancer Treatment to the USA
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and The Ohio State University Forge Landmark Collaboration to Advance Boron Drug Innovation for Precision Cancer Therapy
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and Kyoto University Achieve Breakthrough Preclinical Results in Boron Neutron Capture Therapy (BNCT) with Promising Implications for Cancer Treatment
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and CNAO Announce Definitive Agreement on BNCT, a Next-Generation Cancer Therapy
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Announces Partnership with HDX Corporation for Launch of Boron Neutron Capture Therapy in South Korea
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences to Sponsor Industry Theater Session on the Future of Precision Oncology at 2022 ASTRO Annual Meeting
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Sponsored Study Details Results of Proton Boron Fusion Therapy Biological Effectiveness
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Showcases Targeted Drugs to Support Novel BNCT Accelerator System at 60th PTCOG Conference
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences to Sponsor Industry Expert Theater “New Era in Biologically-Targeted Radiation Therapy” at 2021 ASTRO Annual Meeting
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Partners with BEC to Incorporate Specialized Robotic Patient Positioning System in its Alphabeam™ System for High-Precision Boron Neutron Capture Therapy
From TAE Life Sciences
Via Business Wire
News headline image
TAE Life Sciences Identifies Proprietary Drug Candidates to Support Boron Neutron Capture Therapy (BNCT)
From TAE Life Sciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today